DE60132466D1 - Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen - Google Patents

Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen

Info

Publication number
DE60132466D1
DE60132466D1 DE60132466T DE60132466T DE60132466D1 DE 60132466 D1 DE60132466 D1 DE 60132466D1 DE 60132466 T DE60132466 T DE 60132466T DE 60132466 T DE60132466 T DE 60132466T DE 60132466 D1 DE60132466 D1 DE 60132466D1
Authority
DE
Germany
Prior art keywords
human lung
lung mast
cells
mast cells
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60132466T
Other languages
English (en)
Other versions
DE60132466T2 (de
Inventor
Edward S Schulman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philadelphia Health and Education Corp
Original Assignee
Philadelphia Health and Education Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health and Education Corp filed Critical Philadelphia Health and Education Corp
Publication of DE60132466D1 publication Critical patent/DE60132466D1/de
Application granted granted Critical
Publication of DE60132466T2 publication Critical patent/DE60132466T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
DE60132466T 2000-08-08 2001-08-08 Verfahren zur Herstellung menschlicher Lungenmastzell-Kulturen Expired - Fee Related DE60132466T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22380700P 2000-08-08 2000-08-08
US223807P 2000-08-08
PCT/US2001/025033 WO2002012448A1 (en) 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof

Publications (2)

Publication Number Publication Date
DE60132466D1 true DE60132466D1 (de) 2008-03-06
DE60132466T2 DE60132466T2 (de) 2008-12-24

Family

ID=22838046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132466T Expired - Fee Related DE60132466T2 (de) 2000-08-08 2001-08-08 Verfahren zur Herstellung menschlicher Lungenmastzell-Kulturen

Country Status (8)

Country Link
US (2) US7524679B2 (de)
EP (1) EP1315793B1 (de)
JP (1) JP2004505626A (de)
AT (1) ATE384121T1 (de)
AU (2) AU8478601A (de)
CA (1) CA2419062A1 (de)
DE (1) DE60132466T2 (de)
WO (1) WO2002012448A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2009135001A2 (en) * 2008-04-30 2009-11-05 University Of Pittsburgh- Commonwealth System Of Higher Education Methods and compositions for regulating th2 and th17 responses
CN108865975B (zh) * 2018-07-16 2021-11-23 浙江普罗亭健康科技有限公司 斑块组织消化试剂盒及其应用
CN109852575A (zh) * 2018-12-27 2019-06-07 河北生命原点生物科技有限公司 一种肺泡ⅱ型细胞的分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4117054B2 (ja) * 1998-01-14 2008-07-09 信 川井 抗体及びその製法、この抗体を産生する融合細胞及びその製法、並びにこの抗体に認識される抗原蛋白質
US6080747A (en) * 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
JP4710846B2 (ja) * 2007-02-21 2011-06-29 トヨタ自動車株式会社 内燃機関の排気浄化装置
DE102008036127A1 (de) * 2008-08-01 2010-02-04 Emitec Gesellschaft Für Emissionstechnologie Mbh Verfahren zum Betrieb einer Abgasanlage mit Lambda-Regelung
US8474247B2 (en) * 2009-03-18 2013-07-02 GM Global Technology Operations LLC Particulate filter regeneration post-injection fuel rate control

Also Published As

Publication number Publication date
WO2002012448A1 (en) 2002-02-14
US20040014208A1 (en) 2004-01-22
US20090176880A1 (en) 2009-07-09
JP2004505626A (ja) 2004-02-26
US7524679B2 (en) 2009-04-28
CA2419062A1 (en) 2002-02-14
AU8478601A (en) 2002-02-18
EP1315793A1 (de) 2003-06-04
AU2001284786B2 (en) 2006-04-27
ATE384121T1 (de) 2008-02-15
EP1315793A4 (de) 2004-07-14
EP1315793B1 (de) 2008-01-16
DE60132466T2 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
AR000921A1 (es) Composicion como medio de cultivo para soportar el crecimiento de poblaciones celulares. metodo in vitro para sostener el crecimiento in vitro dede celulas eucarioticas, respectivamente para in vitro incrementar las propiedades del tejido submucoso para cultivar celulas islote o analizar in
DE60139926D1 (de) Methode oder apparat zur kultivierung von zellen oder gewebe
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
WO2004076647A3 (en) Use of steady-state oxygen gradients to modulate animal cell functions
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2001036589A3 (en) Human ex vivo immune system
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
WO2003065999A3 (en) Proliferated cell lines and uses thereof
CA2244659A1 (en) Biological reactor for the cultivation of cells
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
HK1073668A1 (en) A unit and a process for carrying out high cell density fermentation
DK1115840T3 (da) Afstamningsspecifikke celler og progenitorceller
Souza et al. Regeneration of skin tissue promoted by mesenchymal stem cells seeded in nanostructured membrane
AU2003304250A1 (en) Method of isolating cells from umbilical cord
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
RU2006146795A (ru) Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
ATE548447T1 (de) Menschlicher hepatische vorläuferzellen und verfahren zur verwendung davon
DK1242578T3 (da) Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
DE69935999D1 (de) Methoden zur introduktion heterologer zellen in fische
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
HK1070671A1 (en) Cotton rat lung cells for virus culture
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
ATE469209T1 (de) Herstellung und verwendung von basalmembranpartikeln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee